Company Ticker News October 5, 2021Will Regeneron Stock See Lower Levels After Merck's Positive Data? 0 0 Share
Company Ticker News October 4, 2021Here's Why Regeneron (REGN) is Poised for a Turnaround After Losing 16% in 4 Weeks 0 0 Share
Company Ticker News October 1, 2021Is Regeneron Pharmaceuticals (REGN) Outperforming Other Medical Stocks This Year? 0 0 Share
Company Ticker News October 1, 2021Regeneron (REGN) Reports Positive Data on Antibody Cocktail 0 0 Share
Press Release September 30, 2021Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail 0 0 Share
Press Release September 30, 2021New REGEN-COV™ (casirivimab and imdevimab) Data Show Supportive Results in Patients Hospitalized with COVID-19 0 0 Share
Press Release September 28, 2021FDA Accepts Libtayo® (cemiplimab-rwlc) for Priority Review for Advanced Cervical Cancer 0 0 Share
Company Ticker News September 27, 2021Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Cantor Fitzgerald Virtual Global Healthcare 2021 Conference (Transcript) 0 0 Share
